A new study suggests that oncologists can safely pull back on standard locoregional radiotherapy in select patients with cT1-2N1 breast cancer who are treated with primary chemotherapy prior to surgery.
MDedge News
Time to Pull Back on Postsurgery Radiation in Breast Cancer?
